| Today's Open | $2.25 |
|---|---|
| Previous Close | $2.24 |
| Daily Range | $2.23 - $2.34 |
| 52-Week Range | $1.33 - $3.16 |
| Market Cap | $87.8M |
| P/E Ratio | -2.20 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 49,230 |
| Average Daily Volume | 63,565 |
| Current FY EPS | $0.00 |
Sector
Healthcare
Industry
Healthcare Information Services
Enzo Biochem, Inc. (ENZ) Description
The Company is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and a provider of diagnostic services to the medical community. Website: http://www.enzo.com/
News & Commentary
Enzo and NIH File Patent Application for Therapies, Diagnosis, and Prognosis for Autoimmune Diseases
Enzo Biochem Schedules Teleconference to Discuss Second Quarter Results on March 13, 2013 at 8:30 AM
Pre-Market Earnings Report for December 11, 2012 : DG, PTRY, ENZ, HSOL
Pre-Market Earnings Report for December 11, 2012 : DG, PTRY, ENZ, HSOLENZ's Top Competitors
(-0.45%)
(1.79%)
(-1.08%)
(0.64%)